Polymer-Based Paclitaxel-Eluting Stents Are Superior to Nonpolymer-Based Paclitaxel-Eluting Stents in the Treatment of De Novo Coronary Lesions

American Journal of Cardiology

Volumn 98, Issue 8, 2006, Pages 1022-1027

  Iofina, Ekaterina ^a   Langenberg, Roswitha ^a   Blindt, Rüdiger ^a   Kühl, Harald ^a   Kelm, Malte ^a   Hoffmann, Rainer ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; POLYMER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; INTRAVASCULAR ULTRASOUND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STATISTICAL SIGNIFICANCE;

CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RECURRENCE; STENTS; SURVIVAL RATE; TREATMENT OUTCOME; TUBULIN MODULATORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33749241089     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.019     Document Type: Article

References (19)

1. Drachman D.E., Edelman E.R., Seifert P., Groothuis A.R., Bornstein D.A., Kamath K.R., Palasis M., Yang D., Nott S.H., and Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 36 (2000) 2325-2332
2. Herdeg C., Oberhoff M., Baumbach A., Blattner A., Axel D.I., Schroder S., Heinle H., and Karsch K.R. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 35 (2000) 1969-1976
3. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
4. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., et al., TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. TAXUS-II trial. Circulation 108 (2003) 788-794
5. Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., O'Shaughnessy C.D., DeMaio S., Hall P., Popma J.J., et al., TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
6. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes Jr. D.R., Ellis S.G., and Topol E.J. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 (1996) 1690-1697
7. Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., and Kolodgie F.D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
8. Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., Davidson C.J., McKoy J.M., Raisch D.W., Whisenant B.K., et al. Hypersensitivity cases associated with drug-eluting coronary stents. J Am Coll Cardiol 47 (2006) 175-181
9. Virmani R., Liistro F., Stankovic G., Di Mario C., Montorfano M., Farb A., Kolodgie F.D., and Colombo A. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting stent system in humans. Circulation 106 (2002) 2649-2651
10. Grube E., Lansky A., Hauptmann K.E., Di Mario C., Di Sciascio G., Colombo A., Silber S., Stumpf J., Reifart N., Fajadet J., et al., SCORE Randomized Trial. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. J Am Coll Cardiol 44 (2004) 1368-1372
11. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., Song J.K., Kim J.J., Weissman N.J., Fearnot N.E., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
12. Gershlick A., De Scheerder I., Chevalier B., Stephens-Lloyd A., Camenzind E., Vrints C., Reifart N., Missault L., Goy J.J., Brinker J.A., et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial. Circulation 109 (2004) 487-493
13. Lansky A.J., Costa R.A., Mintz G.S., Tsuchiya Y., Midei M., Cox D.A., O'Shaughnessy C., Applegate R.A., Cannon L.A., Mooney M., et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 109 (2004) 1948-1954
14. Heldman A.W., Cheng L., Jenkins G.M., Heller P.F., Kim D.W., Ware Jr. M., Nater C., Hruban R.H., Rezai B., Abella B.S., et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103 (2001) 2289-2295
15. Mehilli J., Kastrati A., Wessely R., Dibra A., Hausleiter J., Jaschke B., Dirschinger J., Schömig A., and Intracoronary Stenting and Angiographic Restenosis-Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investigators. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 113 (2006) 273-279
16. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., Stoll H.P., and REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
17. Windecker S., Remondino A., Eberli F.R., Jüni P., Räber L., Wenaweser P., Togni M., Billinger M., Tüller D., Seiler C., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Eng J Med 353 (2005) 653-662
18. Kastrati A., Mehilli J., Dirschinger J., Dotzer F., Schühlen J., Neumann F.J., Fleckstein M., Pfafferott C., Seyfarth M., and Schömig A. Intracoronary stenting and angiographic results. Strut thickness effect on restenosis outcome (ISAR-STEREO). Circulation 103 (2001) 2816-2821
19. Hoffmann R., Jansen C., König A., Haager P.K., Kerckhoff G., vom Dahl J., Klauss V., Hanrath P., and Mudra H. Stent design related neointimal tissue proliferation in human coronary arteries. Eur Heart J 22 (2001) 2007-2014